Showing results (61-70 of 359) with videos related to

Sort By:
Pageof 36
Clinical Nuclear Medicine|February 2, 2023
Complete Remission Upon Peptide Receptor Radionuclide Therapy in a G2 Pancreatic Neuroendocrine TumorAlexander Weich, Sebastian E Serfling, Heqing Yi, et al.
Clinical Nuclear Medicine|January 23, 2018
Initial Clinical Investigation of [18F]Tetrafluoroborate PET/CT in Comparison to [124I]Iodine PET/CT for Imaging Thyroid CancerSamuel Samnick, Ehab Al-Momani, Jan-Stefan Schmid, et al.
Der Internist|December 30, 2006
[Nuclear medical diagnostics for liver tumors]A K Buck, J C Stollfuss, A Stahl, et al.
Clinical Nuclear Medicine|December 30, 2014
Paralytic subileus as an adverse effect of amino acid-based nephroprotection in a patient undergoing peptide receptor radionuclide therapyRudolf A Werner, Joachim Brumberg, Alexander Dierks, et al.
British Journal of Cancer|November 22, 2012
Dietary patterns and survival in German postmenopausal breast cancer survivorsA Vrieling, K Buck, P Seibold, et al.
The Quarterly Journal of Nuclear Medicine and Molecular Imaging : Official Publication of the Italian Association of Nuclear Medicine (AIMN) [And] the International Association of Radiopharmacology (IAR), [And] Section of the Society Of|January 11, 2012
(18)F-FDG-PET/CT in evaluating response to therapy in solid tumors: where we are and where we can goK Herrmann, M R Benz, B J Krause, et al.
AIDS Care|September 14, 2007
Case management community care for people living with HIV/AIDS (PLHAs)W Husbands, G Browne, J Caswell, et al.
Pageof 36